搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rickettsia rickettsii Ribonuclease P protein component (rnpA) CSB-YP531108RNB
CSB-EP531108RNB
CSB-BP531108RNB
CSB-MP531108RNB
CSB-EP531108RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Ribonuclease PH (rph) CSB-YP531109RNB
CSB-EP531109RNB
CSB-BP531109RNB
CSB-MP531109RNB
CSB-EP531109RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 50S ribosomal protein L5 (rplE) CSB-YP531110RNB
CSB-EP531110RNB
CSB-BP531110RNB
CSB-MP531110RNB
CSB-EP531110RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 50S ribosomal protein L22 (rplV) CSB-YP531111RNB
CSB-EP531111RNB
CSB-BP531111RNB
CSB-MP531111RNB
CSB-EP531111RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii GTPase Der (der) CSB-YP531112RNB
CSB-EP531112RNB
CSB-BP531112RNB
CSB-MP531112RNB
CSB-EP531112RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP531113RNB
CSB-EP531113RNB
CSB-BP531113RNB
CSB-MP531113RNB
CSB-EP531113RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Translation initiation factor IF-1 (infA) CSB-YP531114RNB
CSB-EP531114RNB
CSB-BP531114RNB
CSB-MP531114RNB
CSB-EP531114RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Putative Na (+)/H (+) antiporter nhaA homolog, partial CSB-YP531115RNB
CSB-EP531115RNB
CSB-BP531115RNB
CSB-MP531115RNB
CSB-EP531115RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 50S ribosomal protein L33 (rpmG) CSB-YP531116RNB
CSB-EP531116RNB
CSB-BP531116RNB
CSB-MP531116RNB
CSB-EP531116RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP531117RNB
CSB-EP531117RNB
CSB-BP531117RNB
CSB-MP531117RNB
CSB-EP531117RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP531118RNB1
CSB-EP531118RNB1
CSB-BP531118RNB1
CSB-MP531118RNB1
CSB-EP531118RNB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP531119RNB
CSB-EP531119RNB
CSB-BP531119RNB
CSB-MP531119RNB
CSB-EP531119RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 50S ribosomal protein L28 (rpmB) CSB-YP531120RNB
CSB-EP531120RNB
CSB-BP531120RNB
CSB-MP531120RNB
CSB-EP531120RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP531121RNB
CSB-EP531121RNB
CSB-BP531121RNB
CSB-MP531121RNB
CSB-EP531121RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 30S ribosomal protein S9 (rpsI) CSB-YP531122RNB
CSB-EP531122RNB
CSB-BP531122RNB
CSB-MP531122RNB
CSB-EP531122RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP531123RNB
CSB-EP531123RNB
CSB-BP531123RNB
CSB-MP531123RNB
CSB-EP531123RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Glutamate--tRNA ligase 1 (gltX1) CSB-YP531124RNB
CSB-EP531124RNB
CSB-BP531124RNB
CSB-MP531124RNB
CSB-EP531124RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii NADH-quinone oxidoreductase subunit D (nuoD) CSB-YP531125RNB
CSB-EP531125RNB
CSB-BP531125RNB
CSB-MP531125RNB
CSB-EP531125RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Proline--tRNA ligase (proS) CSB-YP531126RNB
CSB-EP531126RNB
CSB-BP531126RNB
CSB-MP531126RNB
CSB-EP531126RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP531127RNB
CSB-EP531127RNB
CSB-BP531127RNB
CSB-MP531127RNB
CSB-EP531127RNB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>